PROGESTERONE PHARMACEUTICAL COMPOSITION

A progesterone pharmaceutical composition. Specifically, provided is an oral formulation, comprising (a) progesterone; (b) an agent for promoting progesterone bio-utilization; and (c) a pharmaceutically acceptable oral formulation carrier. The agent for promoting progesterone bio-utilization is sele...

Full description

Saved in:
Bibliographic Details
Main Authors SHEN, Jialin, YING, Shengjun, DONG, Yongfeng, YING, Zichao, ZHANG, Xiaoming, SHEN, Zhiqun, FU, Enjun
Format Patent
LanguageChinese
English
French
Published 13.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A progesterone pharmaceutical composition. Specifically, provided is an oral formulation, comprising (a) progesterone; (b) an agent for promoting progesterone bio-utilization; and (c) a pharmaceutically acceptable oral formulation carrier. The agent for promoting progesterone bio-utilization is selected from one or more of sucrose fatty acid esters. The oral formulation is high in bioavailability and low in side effects, making it a superior progesterone oral product. L'invention concerne une composition pharmaceutique de progestérone. Spécifiquement, l'invention concerne une formulation orale, comprenant (a) de la progestérone ; (b) un agent pour favoriser la bio-utilisation de la progestérone ; et (c) un support de formulation orale pharmaceutiquement acceptable. L'agent favorisant la bio-utilisation de la progestérone est choisi parmi un ou plusieurs esters d'acide gras de saccharose. La formulation orale présente une biodisponibilité élevée et des effets secondaires faibles, ce qui permet d'obtenir un pro
Bibliography:Application Number: WO2023CN136525